Association of history of adverse childhood experiences with irritable bowel syndrome (IBS) in individuals with mood disorders.


Journal

Psychiatry research
ISSN: 1872-7123
Titre abrégé: Psychiatry Res
Pays: Ireland
ID NLM: 7911385

Informations de publication

Date de publication:
06 2020
Historique:
received: 11 01 2020
revised: 20 03 2020
accepted: 28 03 2020
pubmed: 28 4 2020
medline: 18 11 2020
entrez: 28 4 2020
Statut: ppublish

Résumé

The objective of the current study was to assess the association between adverse childhood experiences (ACEs) and irritable bowel syndrome (IBS) in mood disorder patients. Self-report data from the International Mood Disorders Collaborative Project were cross-sectionally analyzed to compare rates of IBS in participants with confirmed diagnoses of major depressive disorder (MDD; n = 279) or bipolar disorder (BD; n = 219). Data was sub-grouped and compared based on history of ACEs. In total, 69 of the 498 participants reported a diagnosis of IBS (13.8%). BD was associated with significantly elevated rates of IBS compared to MDD (18.5% versus 10.1% respectively). After adjusting for age and sex, history of childhood sexual abuse was associated with increased rates of IBS in mood disorder participants [adjusted odds ratio (aOR) = 1.95]. In the MDD subgroup, ACEs (all categories and individual categories) were not associated with increased rates of IBS. In the BD subgroup, history of childhood sexual abuse was associated with significantly increased rates of IBS (38% versus 14%; aOR = 3.7). In summary, BD was associated with a higher prevalence of IBS compared to MDD. Additionally, history of sexual abuse was associated with an increased prevalence of IBS in BD, but not in MDD.

Identifiants

pubmed: 32339805
pii: S0165-1781(20)30058-5
doi: 10.1016/j.psychres.2020.112967
pii:
doi:

Types de publication

Letter

Langues

eng

Sous-ensembles de citation

IM

Pagination

112967

Informations de copyright

Copyright © 2020. Published by Elsevier B.V.

Auteurs

Joshua D Rosenblat (JD)

Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.

Rodrigo B Mansur (RB)

Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.

Elisa Brietzke (E)

Department of Psychiatry, Providence Care Hospital, Department of Psychiatry, Queen's University, Kingston, ON, Canada; Department of Psychiatry, Universidade federal de São Paulo, São Paulo, Brazil.

Sidney H Kennedy (SH)

Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Centre for Depression and Suicide Studies, St. Michael's Hospital, Toronto, ON, Canada.

Andre F Carvalho (AF)

Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada.

Yena Lee (Y)

Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada.

Mehala Subramaniapillai (M)

Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada.

David J Muzina (DJ)

Clinical Operations, Quality and Health Services, Medical Mutual of Ohio, USA.

Roman Dale (R)

Lutheran Hospital, Cleveland Clinic Lerner College of Medicine, Cleveland, OH, USA.

Jocelyn K Tamura (JK)

Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada.

Leanna M W Lui (LMW)

Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada.

Caroline Park (C)

Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada.

Lee Phan (L)

Neurosciences & Mental Health, The Hospital for Sick Children, Toronto, ON, Canada.

Raluca M Tuineag (RM)

Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.

Roger S McIntyre (RS)

Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada. Electronic address: roger.mcintyre@uhn.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH